Abstract
AbstractPrecision medicine has a substantial basis in nuclear medicine and found its way into diagnosis and treatment of major and rare diseases. Apart from their scientific basis, further aspects are important for new medical procedures to be introduced into broad clinical care. In this matter, we in Germany have special experiences with PET which is still not fully recognized by statutory health insurances as the standard procedure of choice for many important indications despite its recommendation in international guidelines. This chapter describes the long way of PET and PET/CT into German guidelines and reimbursement for the example of lung cancer, to which the jubilarian made crucial contributions.
Publisher
Springer International Publishing
Reference4 articles.
1. Baum RP, Hellwig D, Mezzetti M. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. Q J Nucl Med Mol Imaging. 2004;48:119–42.
2. Goeckenjan G, Sitter H, Thomas M, et al. Prevention, diagnosis, therapy, and follow-up of lung cancer. Pneumologie. 2010;64(Suppl 2):e1–164.
3. Goeckenjan G, Sitter H, Thomas M, et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie. 2011;65:39–59.
4. Hellwig D, Baum RP, Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin. 2009;48:59–69, quiz N58–59.